is indicated to control the blood glucose level and to reduce the risk of cardiovascular death in patients with type 2 diabetes. It is also used as an aid to diets and exercises to control glycemic level in adults with type 2 diabetes, helping lower blood pressure and weight. It works by stimulating the kidneys to excrete the excessive glucose from the bloodstream through the urine. It is not recommended to the patients with type 1 diabetes.USES
100% Original pharmacy product from German Boehringer Ingelheim https://www.boehringer-ingelheim.com/.
All packs are air tight sealed and expire up to 08.2022.
Jardiance contains Empagliflozin - the inhibitor of sodium-dependent glucose transporter 2 (SGLT2), which reabsorbs glucose from the glomerular filtrate in the kidney. It blocks glucose reabsorption by inhibiting SGLT-2, which results in reduced blood glucose and excreting it via the urine. Empagliflozin also improves HbA1c levels, thus reducing the risk of diabetes-related complications.
Active substance: empagliflozin - 10mg. Excipients: lactose monohydrate - 162.5 mg, microcrystalline cellulose - 62.5 mg, giprolose hydroxypropyl cellulose - 7.5 mg, croscarmellose sodium - 5 mg, silicon dioxide colloid - 1.25 mg, magnesium stearate - 1.25 mg.
Jardiance should be taken orally with or without food at any time of a day.
Recommended starting dose is 1 pill 1 time/day. If needed the dose can be increased up to 25mg. Maximum daily dose is 25mg.
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Jardiance.
|The purpose of the medication||Diabetes Treatment|